Nurses Use Evidence-Based Practice to Bust Oncology Myths
Although nurses strive to promote evidence-based interventions, many practices and beliefs persist despite limited research to support them. During a session on Wednesday, April 10, 2019, at the ONS 44th Annual Congress in Anaheim, CA, Nancy Houlihan, MA, AOCN®, of Memorial Sloan Kettering Cancer Center in New York, NY, Lynn Gallagher-Ford, PhD, RN, NE-BC, DPFNAP, FAAN, of Ohio State University, Helene Fuld Health Trust, National Institute for Evidence-Based Practice in Nursing and Healthcare, in Columbus, and Suzanne Dixon, MPH, MS, RD, of No Nutrition Fear in Portland, OR, instructed nurses on how to be myth busters in oncology practice settings.
AHRQ Shutters National Guideline Clearinghouse Because of Budget Cuts
As of July 16, 2018, the Agency for Healthcare Research and Quality (AHRQ) through the U.S. Department of Health and Human Services ceased maintenance on guideline.gov, the website that housed the National Guideline Clearinghouse. The website had been a resource for healthcare providers for more than 20 years.
How One Institution Used Evidence-Based Practice to Reduce CAUTIs
Catheter-associated urinary tract infections (CAUTIs) are associated with significant morbidity and mortality, with an estimated 93,300 urinary tract infections (UTIs) and 13,000 UTI-related deaths occurring each year in acute care hospitals. A preventable cause of UTIs is the use of long-term indwelling urinary catheters, an ideal focus of evidence-based practice initiatives.
Use These Methods to Evaluate EBP Outcomes and Disseminate Results
One of the most important but often challenging steps in the evidence-based practice (EBP) process is ensuring that the change we wanted to happen actually occurred. After a practice change has been implemented, it’s important to ask if the expected outcome was achieved. Patient-related outcomes can be psychosocial (change in symptoms such as depression or anxiety), physiologic (reduction in catheter-associated urinary tract infections), or functional (increased exercise or mobility). Outcomes can also be process related, such as reduced readmissions or more efficient discharge planning.
Integrate Evidence With Clinical Expertise and Patient Preferences and Values
Nursing is often referred to as both an art and a science. Evidence-based practitioners must combine understanding the science of health, illness, and disease with the art of adapting care to individual patients and situations, all while thinking critically to improve patient outcomes.
Search the Literature to Critically Appraise Evidence
Changes in technology have brought about significant opportunities in how we identify and manage information. We have access to published research and clinical articles from thousands of journals to answer clinical questions. Finding the right information can be challenging, but building your skills in searching for evidence and synthesizing evidence is critical to becoming an evidence-based practice expert. Here’s how to proceed.
Strengthen a Commitment to Practice Change Through EBP Immersions
That “science, informatics, incentives, and culture are aligned for continuous improvement and innovation” in care delivery through evidence-based practice (EBP) that uses research outcomes, clinical expert perspectives, and patient and family engagement, the National Academy of Medicine Roundtable on Value and Science-Driven Health Care project charter visualizes. By 2020, the goal is to ensure that 90% of clinical decisions are individualized yet supported by the most current, relevant, and best-available evidence and effective tools are in place to measure outcomes.
Adopt an Evidence-Based Practice Model to Facilitate Practice Change
Evidence-based practice (EBP) results from the integration of available research, clinical expertise, and patient preferences to individualize care and promote effective care decision-making. Oncology nurses are perfectly positioned to be adopters and promoters of EBP, resulting in practice change for improved quality and safety.
Manage Pain in Patients With Cancer With These Tools and Resources
One distinct, uniquely personal symptom unifies almost all patients with cancer: pain. It can be as wildly varied and different as each patient it affects. It can be acute, sudden experiences of pain, or the symptoms can be chronic and perpetual. Patients undergoing the treatments associated with cancer often suffer varying degrees of pain through their cancer journeys, which leads to significant physical and psychosocial burdens. This can decrease their quality of life and potentially impact their overall outcomes. A 2015 National Comprehensive Cancer Network report suggested that the evidence suggests a clear link between improved survival outcomes and adequate symptom management.
The Difference Between Quality Improvement, Evidence-Based Practice, and Research
As healthcare institutions become ever more complex and our focus on patient experience expands, nurses are leading and participating in research studies, evidence-based practice (EBP) projects, and quality improvement (QI) initiatives with a goal of improving patient outcomes. Research, EBP, and QI have subtle differences and frequent overlap, which can make it a challenge for nurses to identify the best option to investigating a clinical problem.
Evidence-Based Standards Guide the Use and Maintenance of Venous Implanted Ports
Implanted ports are an important lifeline for patients receiving antineoplastic treatments; however, despite vast nursing research on the maintenance and utilization of venous implanted ports, still so much remains to be learned. Many of the practices surrounding implanted ports remain controversial.
Massage Has Therapeutic Value for Patients With Cancer
An ancient form of bodywork that encompasses hands-on manipulation of muscles and soft tissues, massage increases circulation, reduces muscular tension and promotes relaxation. It also produces emotional and psychological benefits.
FDA Approves L-Glutamine Powder for the Treatment of Sickle Cell Disease
On July 7, 2017, the U.S. Food and Drug Administration (FDA) approved L-glutamine oral powder for oral administration to reduce the acute complications of sickle cell disease in adult and pediatric patients five years and older.